07:00 , Sep 1, 2014 |  BC Week In Review  |  Financial News

Armetheon completes venture financing

Armetheon Inc. , Menlo Park, Calif.   Business: Cardiovascular, Infectious   Date completed: 2014-08-28   Type: Venture financing   Raised: $7 million   Investors: AshHill Biomedical Investments; Hercules Bioventures; Atheneos Capital; individual investor  ...
07:00 , Jun 11, 2012 |  BioCentury  |  Emerging Company Profile

Armetheon: Stopping the bleeding

Former ARYx Therapeutics Inc. President Peter Milner co-founded Armetheon Inc. to take a second shot at developing tecarfarin three years after the ARYx anticoagulant failed a Phase II/III trial to prevent blood clots. This time...
07:00 , Apr 12, 2010 |  BC Week In Review  |  Financial News

Altheos completes venture financing

Altheos Inc. , South San Francisco, Calif.   Business: Ophthalmic   Date completed: 4/5/10   Type: Venture financing   Raised: $20 million   Investors: Bay City Capital; Novo A/S; Canaan Partners; Life Science Angels Inc.;...
07:00 , Apr 12, 2010 |  BioCentury  |  Strategy

Altheos Mines its Rho-lodex

After concluding that all the interesting new projects in the U.S. and Europe had been picked over, the founders of Altheos Inc. turned to Asia to find assets for in-licensing. Based on the strength of...
00:56 , Apr 6, 2010 |  BC Extra  |  Financial News

Altheos raises $20M, in-licenses glaucoma compound

Altheos Inc. (South San Francisco, Calif.) raised $20 million in a series A round on Monday and announced a deal with Asahi Kasei Pharma Corp. Asahi granted Altheos exclusive, worldwide rights, excluding Japan and Korea,...